Human Neural Precursors from CNS Developmental Disorders: Down Syndrome
Human Neural Precursors from CNS Developmental Disorders: Down Syndrome
批准号:
7602965
负责人:
VOLNEY L SHEEN
金额:
$25.5万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-04 至 2011-03-31
关键词:
ARNT2 geneAdoptedAgeAlzheimer&aposs DiseaseAmyloid beta-Protein PrecursorBrainCalcium-Binding ProteinsCell DeathCell LineCharacteristicsChromosomes, Human, Pair 21Congenital AbnormalityCongenital Heart DefectsDataDefectDevelopmentDiseaseDown SyndromeFaceFinancial compensationFree RadicalsGene DuplicationGene ExpressionGene Expression ProfileGenesGenomeGoalsHIF1A geneHearing problemHumanHuman BiologyHuman IdentificationsIn VitroIndividualInfectionInjuryIntervention StudiesLeadMediatingMental RetardationMessenger RNAModelingMolecularMolecular ProfilingNetwork-basedNeurologicNeuronsPathway AnalysisPathway interactionsPhenotypeProcessProteinsReactive Oxygen SpeciesSamplingSeizuresTechniquesTechnologyTestingTherapeutic InterventionTissuesUp-RegulationVisionaquaporin 4brain tissuecell typedevelopmental diseasegenome-widehuman stem cellsinsightmRNA Expressionmouse Trisomy 16mouse modelnerve stem cellnew therapeutic targetnormal agingprematureprogenitorpublic health relevanceresponsestem cell populationwater channel
中文摘要
描述(由申请人提供):唐氏综合征(DS)是一种常见的发育障碍,由21号染色体重复引起。理解导致DS的主要神经学特征的发育机制,即MR、癫痫发作和早发性阿尔茨海默病(AD),将取决于DS发育中观察到的差异的表征,而不是正常大脑。各种小鼠模型已被用作实验范式来理解这种差异,但在解释这些研究时存在明显的局限性,特别是因为人类大脑的生物学与其他物种不同。此外,DS脑的许多神经病理学特征 即改变的增殖、细胞死亡和神经元发生提示神经干细胞(NSC)群体内的缺陷。因此,我们建议调查来自唐氏综合征脑的人神经干细胞的mRNA谱,并表征在这种体外发育模型中被破坏的细胞和分子因子。我们假设人类DS NSC中21号染色体上基因表达的改变将导致整个基因组中可识别的mRNA表达变化,并且这些变化可能与有助于DS CNS表型的特定功能途径相关。我们提出了一个两部分的研究,涉及人类DS神经祖细胞,调查DS皮质发育的机制:具体目标1:使用验证技术的定量mRNA分析技术,我们将确定基因改变的mRNA表达谱的多个人类DS神经祖细胞系相比,年龄匹配的控制和使用网络分析,以确定相互作用的蛋白质和发育途径的DS重要。具体目标二:我们将测试先前目标中预测的功能变化是否在DS NSC和人或16三体小鼠组织中明显。通过定量mRNA分析相当均匀的人类DS神经前体细胞和DS神经前体细胞在体外的功能分析,我们希望获得额外的洞察这种常见疾病的机制,并提供潜在的场所,发现新的治疗靶点。唐氏综合症(DS)是人类最常见的发育障碍之一,由21号染色体上的基因异常复制引起。目前的提议旨在从DS脑中产生和研究人类干细胞。了解在这种疾病中被破坏的基因将允许开发治疗干预措施。
英文摘要
DESCRIPTION (provided by applicant): Down syndrome (DS) is a common developmental disorder caused by a duplication of chromosome 21. Understanding the developmental mechanisms that lead to the primary neurological features of DS, namely MR, seizures, and premature Alzheimer's disease (AD), will depend upon characterization of the differences observed in the development of the DS, as opposed to normal brain. Various mouse models have been used as experimental paradigms to understand such differences, but clear limitations exist in the interpretation of these studies, particularly since the biology of human brains are different from those of other species. Moreover, many of the neuropathological features of DS brain namely altered proliferation, cell death, and neuronogenesis suggest a defect within the neural stem cell (NSC) population. Thus, we propose to investigate the mRNA profiles of human NSCs derived from Down syndrome brain and characterize the cellular and molecular factors which are disrupted in this vitro developmental model. We hypothesize that altered expression of genes on chromosome 21 in human DS NSCs will lead to identifiable mRNA expression changes throughout the genome, and that these changes can be associated with specific functional pathways that will contribute to the DS CNS phenotype. We propose a two-part study involving human DS neural progenitors, to investigate the mechanisms of DS cortical development: Specific Aim 1: Using validated techniques of quantitative mRNA profiling technology, we will identify genes altered on mRNA expression profiles of multiple human DS neural progenitor lines as compared to age-matched controls and use network analysis to identify interacting proteins and developmental pathways important for DS. Specific Aim 2: We will test whether the functional changes predicted in the prior aim are apparent in the DS NSCs and human or trisomy 16 mouse tissues. Through quantitative mRNA analyses of fairly uniform human DS neural progenitors and functional analyses of DS neural precursors in vitro, we hope to gain additional insight into mechanisms underlying this common disorder and provide potential venues for the discovery of new therapeutic targets. PUBLIC HEALTH RELEVANCE Down Syndrome (DS) is one of the most common developmental disorders in humans and is caused by the abnormal duplication of genes on chromosome 21. The current proposal seeks to generate and study human stem cells from DS brain. Understanding the genes which are disrupted in this disorder will allow for the development of therapeutic interventions.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3791/2681
发表时间:
2011-05-25
期刊:
Journal of visualized experiments : JoVE
影响因子:
--
作者:
[Lu, Jie, Delli-Bovi, Laurent C, Sheen, Volney L]
通讯作者:
Sheen, Volney L
Seizure or syncope: lessons over time.
癫痫发作或晕厥:随着时间的推移吸取教训。
DOI:
10.1016/j.jocn.2011.06.017
发表时间:
2012
期刊:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
影响因子:
--
作者:
[Sheen,VolneyL]
通讯作者:
Sheen,VolneyL
DOI:
10.1021/bm201372u
发表时间:
2012-02-13
期刊:
BIOMACROMOLECULES
影响因子:
6.2
作者:
[Cai, Lei, Lu, Jie, Sheen, Volney, Wang, Shanfeng]
通讯作者:
Wang, Shanfeng
Optimal poly(L-lysine) grafting density in hydrogels for promoting neural progenitor cell functions.
DOI:
10.1021/bm300381d
发表时间:
2012-05-14
期刊:
BIOMACROMOLECULES
影响因子:
6.2
作者:
[Cai, Lei, Lu, Jie, Sheen, Volney, Wang, Shanfeng]
通讯作者:
Wang, Shanfeng
DOI:
10.1111/j.1582-4934.2008.00159.x
发表时间:
2008-06
期刊:
Journal of cellular and molecular medicine
影响因子:
5.3
作者:
[Esposito G, Scuderi C, Lu J, Savani C, De Filippis D, Iuvone T, Steardo L Jr, Sheen V, Steardo L]
通讯作者:
Steardo L
共 8 条
Down Syndrome: a potential treatment XISTs
-
批准号:10525816
-
项目类别:
-
资助金额:$169.33万
-
财政年份:2022
-
负责人:VOLNEY L SHEEN
-
依托单位:
Epigenetic Silencing of HSA21 in Down Syndrome
-
批准号:10016836
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2019
-
负责人:VOLNEY L SHEEN
-
依托单位:
Deciphering HSA21 genes associated with Alzheimers disease in Down Syndrome
-
批准号:10120793
-
项目类别:
-
资助金额:$28.19万
-
财政年份:2019
-
负责人:VOLNEY L SHEEN
-
依托单位:
Epigenetic Silencing of HSA21 in Down Syndrome
-
批准号:9892127
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2019
-
负责人:VOLNEY L SHEEN
-
依托单位:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
-
批准号:8269069
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2009
-
负责人:VOLNEY L SHEEN
-
依托单位:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
-
批准号:7729307
-
项目类别:
-
资助金额:$29.75万
-
财政年份:2009
-
负责人:VOLNEY L SHEEN
-
依托单位:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
-
批准号:8470253
-
项目类别:
-
资助金额:$28.13万
-
财政年份:2009
-
负责人:VOLNEY L SHEEN
-
依托单位:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
-
批准号:8078196
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2009
-
负责人:VOLNEY L SHEEN
-
依托单位:
Human Neural Precursors from CNS Developmental Disorders: Down Syndrome
-
批准号:7470915
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2008
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6361362
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6755157
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6896101
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6539295
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6608616
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
LOCAL MICROENVIRONMENTAL CONTROL OF NEURAL SPECIFICATION
-
批准号:2430901
-
项目类别:
-
资助金额:$0.14万
-
财政年份:1997
-
负责人:VOLNEY L SHEEN
-
依托单位:
LOCAL MICROENVIRONMENTAL CONTROL OF NEURAL SPECIFICATION
-
批准号:2242517
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1996
-
负责人:VOLNEY L SHEEN
-
依托单位:
LOCAL MICROENVIRONMENTAL CONTROL OF NEURAL SPECIFICATION
-
批准号:2242516
-
项目类别:
-
资助金额:$2.35万
-
财政年份:1995
-
负责人:VOLNEY L SHEEN
-
依托单位:
海外基金